Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 139

1.

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B.

Gane EJ, Wang Y, Liaw YF, Hou J, Thongsawat S, Wan M, Moon YM, Jia J, Chao YC, Niu J, Leung N, Samuel D, Hsu CW, Bao W, Lopez P, Avila C.

Liver Int. 2011 May;31(5):676-84. doi: 10.1111/j.1478-3231.2011.02490.x. Epub 2011 Mar 16.

PMID:
21457439
[PubMed - indexed for MEDLINE]
2.

Efficacy of switching to telbivudine in chronic hepatitis B patients treated previously with lamivudine.

Safadi R, Xie Q, Chen Y, Yin YK, Wei L, Hwang SG, Zuckerman E, Jia JD, Lopez P.

Liver Int. 2011 May;31(5):667-75. doi: 10.1111/j.1478-3231.2010.02360.x. Epub 2010 Oct 29.

PMID:
21040410
[PubMed - indexed for MEDLINE]
3.

2-Year GLOBE trial results: telbivudine Is superior to lamivudine in patients with chronic hepatitis B.

Liaw YF, Gane E, Leung N, Zeuzem S, Wang Y, Lai CL, Heathcote EJ, Manns M, Bzowej N, Niu J, Han SH, Hwang SG, Cakaloglu Y, Tong MJ, Papatheodoridis G, Chen Y, Brown NA, Albanis E, Galil K, Naoumov NV; GLOBE Study Group.

Gastroenterology. 2009 Feb;136(2):486-95. doi: 10.1053/j.gastro.2008.10.026. Epub 2008 Nov 1.

PMID:
19027013
[PubMed - indexed for MEDLINE]
4.

A comparison of telbivudine and entecavir for chronic hepatitis B in real-world clinical practice.

Tsai MC, Lee CM, Chiu KW, Hung CH, Tung WC, Chen CH, Tseng PL, Chang KC, Wang JH, Lu SN, Yen YH, Hu TH.

J Antimicrob Chemother. 2012 Mar;67(3):696-9. doi: 10.1093/jac/dkr495. Epub 2011 Dec 15.

PMID:
22174039
[PubMed - indexed for MEDLINE]
Free Article
5.

Telbivudine versus lamivudine in patients with chronic hepatitis B.

Lai CL, Gane E, Liaw YF, Hsu CW, Thongsawat S, Wang Y, Chen Y, Heathcote EJ, Rasenack J, Bzowej N, Naoumov NV, Di Bisceglie AM, Zeuzem S, Moon YM, Goodman Z, Chao G, Constance BF, Brown NA; Globe Study Group.

N Engl J Med. 2007 Dec 20;357(25):2576-88.

PMID:
18094378
[PubMed - indexed for MEDLINE]
Free Article
6.

[The efficacy and safety of telbivudine in korean patients with chronic hepatitis B].

Moon YM, Hwang SG, Kim BS, Rim KS, Cho M, Kim DJ, Han JY, Kim YS, Choi HS, Ahn SH.

Korean J Hepatol. 2007 Dec;13(4):503-12. Korean.

PMID:
18159148
[PubMed - indexed for MEDLINE]
Free Article
7.

Serum HBV DNA level at week 12 is superior to viral response at week 24 in predicting long-term treatment outcome of telbivudine for chronic hepatitis B patients.

Lü W, Yang HH, Fan YM, Li T, Zhang LF, Mui C, Fan HW, Zhou BT, Liu ZY, Ng H, Liu XQ.

Chin Med J (Engl). 2013 Jun;126(12):2333-6.

PMID:
23786949
[PubMed - indexed for MEDLINE]
8.
9.

Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome.

Seto WK, Lai CL, Fung J, Wong DK, Yuen JC, Hung IF, Yuen MF.

J Hepatol. 2011 Sep;55(3):522-8. doi: 10.1016/j.jhep.2010.11.018. Epub 2010 Dec 13.

PMID:
21147187
[PubMed - indexed for MEDLINE]
10.

Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B.

Wang Y, Thongsawat S, Gane EJ, Liaw YF, Jia J, Hou J, Chan HL, Papatheodoridis G, Wan M, Niu J, Bao W, Trylesinski A, Naoumov NV.

J Viral Hepat. 2013 Apr;20(4):e37-46. doi: 10.1111/jvh.12025. Epub 2012 Dec 27.

PMID:
23490388
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B.

Lai CL, Leung N, Teo EK, Tong M, Wong F, Hann HW, Han S, Poynard T, Myers M, Chao G, Lloyd D, Brown NA; Telbivudine Phase II Investigator Group.

Gastroenterology. 2005 Aug;129(2):528-36.

PMID:
16083710
[PubMed - indexed for MEDLINE]
12.

Efficacy of telbivudine in HBeAg-positive chronic hepatitis B patients with high baseline ALT levels.

Lv GC, Ma WJ, Ying LJ, Jin X, Zheng L, Yang YD.

World J Gastroenterol. 2010 Aug 28;16(32):4095-9.

PMID:
20731026
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study.

Huang Z, Zhao Z, Zheng Y, Peng L, Lin C, Deng H, Gao Z.

J Viral Hepat. 2013 Apr;20 Suppl 1:52-7. doi: 10.1111/jvh.12064.

PMID:
23458525
[PubMed - indexed for MEDLINE]
14.

Telbivudine plus adefovir therapy for chronic hepatitis B patients with virological breakthrough or genotypic resistance to telbivudine.

Zhang Y, Lian JQ, Li Y, Wang JP, Huang CX, Bai XF, Wang JP.

Eur J Gastroenterol Hepatol. 2013 Jul;25(7):814-9. doi: 10.1097/MEG.0b013e32835ee516.

PMID:
23406845
[PubMed - indexed for MEDLINE]
15.

52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B.

Piratvisuth T, Komolmit P, Tanwandee T, Sukeepaisarnjaroen W, Chan HL, Pessôa MG, Fassio E, Ono SK, Bessone F, Daruich J, Zeuzem S, Cheinquer H, Pathan R, Dong Y, Trylesinski A.

PLoS One. 2013;8(2):e54279. doi: 10.1371/journal.pone.0054279. Epub 2013 Feb 4.

PMID:
23390496
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Efficacy of telbivudine in Taiwanese chronic hepatitis B patients compared with GLOBE extension study and predicting treatment outcome by HBV DNA kinetics at week 24.

Hsu CW, Chao YC, Lee CM, Chang TT, Chen YC.

BMC Gastroenterol. 2012 Dec 13;12:178. doi: 10.1186/1471-230X-12-178.

PMID:
23234302
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-term treatment with adefovir.

Hadziyannis SJ, Sevastianos V, Rapti I, Vassilopoulos D, Hadziyannis E.

Gastroenterology. 2012 Sep;143(3):629-36.e1. doi: 10.1053/j.gastro.2012.05.039. Epub 2012 May 31.

PMID:
22659218
[PubMed - indexed for MEDLINE]
18.

Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.

Sarin SK, Kumar M, Kumar R, Kazim SN, Guptan RC, Sakhuja P, Sharma BC.

Am J Gastroenterol. 2005 Nov;100(11):2463-71.

PMID:
16279901
[PubMed - indexed for MEDLINE]
19.

An observational study to evaluate the safety and efficacy of telbivudine in adults with chronic hepatitis B.

Sulaiman A, Lesmana LA, Nafrialdi, Helyanna.

Acta Med Indones. 2014 Jan;46(1):38-43.

PMID:
24760807
[PubMed - indexed for MEDLINE]
Free Article
20.

Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir.

Park H, Park JY, Kim SU, Kim do Y, Han KH, Chon CY, Ahn SH.

World J Gastroenterol. 2013;19(43):7671-9. doi: 10.3748/wjg.v19.i43.7671.

PMID:
24431895
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk